Singular Genomics Systems (OMIC)
NASDAQ:OMIC
US Market

Singular Genomics Systems (OMIC) Financial Statements

70 Followers

Singular Genomics Systems Financial Overview

Singular Genomics Systems's market cap is currently ―. The company's EPS TTM is $-39.386; its P/E ratio is -0.21; Singular Genomics Systems is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-8.86. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 442.00K$ 1.08M$ 462.00K$ 505.00K$ 863.00K
Gross Profit$ -419.00K$ -457.00K$ -65.00K$ 505.00K$ 56.00K
EBIT$ -24.74M$ -22.96M$ -22.07M$ -25.31M$ -25.38M
EBITDA$ -23.73M$ -20.32M$ -19.43M$ -23.66M$ -22.20M
Net Income Common Stockholders$ -25.02M$ -23.25M$ -22.36M$ -25.58M$ -23.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 150.74M$ 173.94M$ 190.72M$ 206.68M$ 226.07M
Total Assets$ 239.10M$ 265.47M$ 284.52M$ 283.98M$ 305.47M
Total Debt$ 73.54M$ 75.29M$ 77.00M$ 58.39M$ 58.60M
Net Debt$ -77.20M$ -98.65M$ -113.71M$ -148.29M$ -167.47M
Total Liabilities$ 82.40M$ 86.46M$ 85.49M$ 65.59M$ 65.14M
Stockholders Equity$ 156.70M$ 179.01M$ 199.03M$ 218.39M$ 240.32M
Cash Flow-
Free Cash Flow$ -23.73M$ -19.29M$ -16.92M$ -20.30M$ -18.10M
Operating Cash Flow$ -23.70M$ -18.90M$ -16.81M$ -20.00M$ -17.93M
Investing Cash Flow$ 31.58M$ 651.00K$ -24.70M$ -35.09M$ 72.94M
Financing Cash Flow-$ 72.00K-$ 618.00K$ 6.00K
Currency in USD

Singular Genomics Systems Earnings and Revenue History

Singular Genomics Systems Debt to Assets

Singular Genomics Systems Cash Flow

Singular Genomics Systems Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis